Michigan - Pancreatic Cancer Action Network

We’ve seen a momentous advance this year — FDA approval of a treatment targeting the mutations that drive more than 90% of pancreatic cancer cases. And right now, more drugs are in the pipeline than ever before, signaling a new generation of therapies poised to transform what’s possible. It’s time to move faster and push science to reach every patient who needs it. 💜 Visit 🔗 pancan.org/awareness to join the movement.

This Pancreatic Cancer Awareness Month, we're coming together to change the story of pancreatic cancer. 💜 Through breakthrough research, patient support, advocacy and the power of our community, PanCAN is driving progress and bringing hope to everyone affected by this disease. Behind every breakthrough is a community of survivors, families, researchers, advocates and supporters who believe a better future is possible. Together, we're working toward earlier detection, better treatments and a world where survival is the expectation, not the exception. The progress we've made is only the beginning. There's more to do, and it will take all of us, together. All together, we can turn science into survival. Visit 🔗 pancan.org/awareness to learn more and get involved.

On the latest episode of PancChat, host @AlisynCamerota is joined by Dr. Diane Reidy-Lagunes of @DukeHealth to discuss managing pancreatic neuroendocrine tumors, also known as PNETs. Visit 🔗 pcan.at/PancChat to listen. The PancChat podcast is a collaboration between @LetsWinPC and PanCAN, and this episode is sponsored by @RevMedicines. 💜

On World Pancreatic Cancer Day, join PanCAN for a Right Track Live virtual event focused on helping patients, caregivers and loved ones better understand early detection for pancreatic cancer. PanCAN Chief Scientific and Medical Officer @ABerkenblit, MD, MMSc, will host a panel of special guests: 🔎 Avinash Kambadakone, MD Radiologist, Chief, Abdominal Radiology, Mass General Brigham 🔎 Bechien Wu, MD, MPH Gastroenterologist, Physician Director, Division of Clinical Research, Kaiser Permanente 🔎 Nipun Merchant, MD (@NbmerchantMD) Surgeon, Vice Chair of Surgical Oncologic Services, University of Miami Miller School of Medicine 🔎 Diane Simeone, MD (@MadameSurgeon) Surgeon, Director, Moores Cancer Center, UC San Diego Health Visit 🔗 pcan.at/RightTrackLive to save your virtual seat today!

We are saddened to acknowledge the passing of actress Susan Saint James, who died of pancreatic cancer at age 80. She was best known for her roles in the television series "McMillan & Wife" and "Kate & Allie." In 2026, an estimated 67,530 people in the U.S. will be diagnosed with pancreatic cancer and approximately 52,740 will die from the disease. Learn more about pancreatic cancer and how PanCAN is working to accelerate progress toward better outcomes for patients at 🔗 pancan.org. 📷: AP News

At a time of extraordinary progress in pancreatic cancer research and treatment, we’re grateful for the support of our PanCAN Scientific & Medical Affairs Industry Champions, including our newest Champions: @ClearNoteHealth, @Immunovia, Tango Therapeutics and returning Champions @AstellasUS and Ipsen. Together, we’re turning science into survival. 💜

There are several risk factors for pancreatic cancer. Could you be at higher risk? Take the test to learn more and get next steps. 💜 pancan.org/facing-pancreatic…

Today, we remember Days of our Lives actor Drake Hogestyn, who passed away from pancreatic cancer in 2024 — just one day before his 71st birthday. His legacy lives on through his family and @DaysPeacock castmates, who come together at #PanCANPurpleStride, our biggest community event of the year, in his memory. In 2025, cast members formed Team Hogey’s Home Runners to honor their friend and co-star, returning again in 2026 to take steps to end pancreatic cancer. 💜 In 2026, an estimated 67,530 people in the U.S. will be diagnosed with pancreatic cancer, and approximately 52,740 will die from the disease. Learn more about pancreatic cancer and how we’re turning science into survival at 🔗 pancan.org. 📷: AoL

On this episode of PancChat, host @AlisynCamerota is joined by Dr. Eileen O’Reilly of @MSKCancerCenter to discuss what the recent approval of RASONQUE™ (daraxonrasib) means for people with pancreatic cancer. 💊 Dr. O’Reilly breaks down RAS signaling, common RAS mutations including G12D, G12V and G12R, how RAS-targeting drugs work, what RAS mutation testing involves and what “RAS wild type” means. Visit 🔗 pcan.at/PancChat to listen. The PancChat podcast is a collaboration between @LetsWinPC and PanCAN, and this episode is sponsored by @RevMedicines.